IMPORTANT PACS DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Promotes PACS Group Inc. Investors With Losses Exceeding $100K To Protect Advice Before Critical Deadline In Securities Class Action

New York, New York–(Newsfile Corp. – January 1, 2025) – WHY: The Rosen Law Firm, a global investor rights law firm, reminds clients of PACS Group Inc. (NYSE: PACS) (i) for common stock pursuant to and/or traceable to the registration statement and prospectus (collectively, the “Registration Statement”) in connection with the Company’s initial public offering dated April 11, 2024 (“IPO”); (ii) securities between April 11, 2024 and November 5, 2024, both dates included (the “Class Period”); and/or (iii) common stock pursuant to and/or traceable to the registration statement and prospectus issued in connection with the Company’s September 2024 secondary public offering (“SPO”), of material importance. January 13, 2025 is the deadline for the plaintiff.

NOW: If you purchased PACS common stock pursuant to and/or traceable to the IPO and/or securities during the Class Period you may be entitled to compensation without payment of any out-of-pocket payments or expenses through a contingency fee arrangement.

WHAT YOU NEED TO DO: To join a PACS class action, visit or call Phillip Kim, Esq. toll free at 866-767-3653 or email case@rosenlegal.com for information about the class action. A class action lawsuit has already been filed. If you wish to act as a lead plaintiff, you must remove the Court no later than January 13, 2025. The lead plaintiff is the organization representing the other members of the class directing the lawsuit.

WHY THE LAW WENT OUT: We encourage investors to select qualified advisors with a track record of success in leadership roles. Generally, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these companies are not responsible for the actions of the security department, but they are partners who send customers or partners with law firms who prosecute cases. Be wise in choosing advice. The Rosen Law Firm represents investors worldwide, focusing its practice on securities class actions and shareholder exit litigation. The Rosen Law Firm won the largest securities class action settlement ever against a Chinese Company at the time. The Rosen Law Firm is ranked #1 by ISS Securities Class Action (WA:) Value services for securities class agreements in 2017. The company has been listed in the top 4 every year since 2013 and has returned hundreds of millions of dollars to investors. In 2019 alone the company secured more than 438 million from investors. In 2020, founding partner Laurence Rosen was named by Law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s lawyers are recognized by Lawdragon and Super Lawyers.

CASE DETAILS: According to the lawsuit, in the Registration Statement and throughout the Class Period, the defendants made false and/or misleading statements and/or failed to disclose that: (1) PACS engaged in a “campaign” to submit false Medicare claims that “drove in excess of 100% of PACS’ operations and revenues from 2020 – 2023”; (2) PACS devised a “scheme” to “bill thousands of unnecessary respiratory and neuroimaging therapies on Medicare”; (3) PACS engaged in a scheme to falsify documents related to licensing and employment; and (4) because of the foregoing, defendants’ positive statements about PACS’ business, operations, and prospects were grossly misleading and/or lacked a reasonable basis. When true information enters the market, the lawsuit claims that investors suffered damages.

To join a PACS class action, visit or call Phillip Kim, Esq. toll free at 866-767-3653 or email case@rosenlegal.com for information about the class action.

No Class Guaranteed. Until the class is certified, you are not represented by an attorney unless you retain it. You can choose the advice of your choice. You can also remain a member of the missing class and do nothing for now. The investor’s ability to participate in any potential future returns is not dependent on performance as the lead claimant.

Follow us for updates on LinkedIn: on Twitter: or on Facebook (NASDAQ:):

Advocate advertising. Previous results do not guarantee the same result.

——————————

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/235491